K

Kotra Industries Bhd
KLSE:KOTRA

Watchlist Manager
Kotra Industries Bhd
KLSE:KOTRA
Watchlist
Price: 4.17 MYR -0.71% Market Closed
Market Cap: 618.5m MYR

Operating Margin
Kotra Industries Bhd

21.1%
Current
25%
Average
6.1%
Industry

Operating Margin represents how efficiently a company is able to generate profit through its core operations.

Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.

Operating Margin
21.1%
=
Operating Profit
48.7m
/
Revenue
230.8m

Operating Margin Across Competitors

Country Company Market Cap Operating
Margin
MY
Kotra Industries Bhd
KLSE:KOTRA
618.5m MYR
21%
US
Eli Lilly and Co
NYSE:LLY
997.2B USD
44%
UK
Dechra Pharmaceuticals PLC
LSE:DPH
440.4B GBP
3%
US
Johnson & Johnson
NYSE:JNJ
503.6B USD
27%
CH
Roche Holding AG
SIX:ROG
252.5B CHF
34%
UK
AstraZeneca PLC
LSE:AZN
211.1B GBP
24%
CH
Novartis AG
SIX:NOVN
205.8B CHF
33%
US
Merck & Co Inc
NYSE:MRK
244.4B USD
38%
DK
Novo Nordisk A/S
CSE:NOVO B
1.4T DKK
42%
IE
Endo International PLC
LSE:0Y5F
209B USD
11%
US
Pfizer Inc
NYSE:PFE
145.2B USD
29%
No Stocks Found

Kotra Industries Bhd
Glance View

Market Cap
618.5m MYR
Industry
Pharmaceuticals

Kotra Industries Bhd.is an investment holding company, which engages in the manufacturing and trading of pharmaceutical and healthcare products. The company is headquartered in Malacca, Melaka and currently employs 660 full-time employees. The company went IPO on 2000-10-30. The Company, through its subsidiary, Kotra Pharma (M) Sdn. Bhd, is engaged in pharmaceutical and healthcare products manufacturing and trading business. Its segments include Malaysia, Asia and Africa. Its products include Appeton Multivitamin Pastilles, which is a healthy chewable pastille (non-sugar coated) for children; Axcel Glimepiride Medication, which is used to treat diabetes mellitus type 2; Axcel Bromhexine (Children) Syrup, which is a mucolytic medicine used in the treatment of respiratory chest congestion; Arite Beclometasone 50mcg (Metered Dose Inhaler Product), which is used in long-term management of asthma; Vaxcel Granisetron Injection, which is an antiemetic to treat nausea and vomiting following chemotherapy and radiotherapy, and Axcel Atenolol, which is used to treat high blood pressure and heart-associated chest pain.

KOTRA Intrinsic Value
4.44 MYR
Undervaluation 6%
Intrinsic Value
Price
K
What is Operating Margin?

Operating Margin represents how efficiently a company is able to generate profit through its core operations.

Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.

Operating Margin
21.1%
=
Operating Profit
48.7m
/
Revenue
230.8m
What is the Operating Margin of Kotra Industries Bhd?

Based on Kotra Industries Bhd's most recent financial statements, the company has Operating Margin of 21.1%.

Back to Top